While CVS Health (CVS) has been grappling with the pharmacy reimbursement pressure, a turnaround might be in the cards given its several strategic initiatives.
CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2024, to holders of record on July 22, 2024.
CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7th, 2024, at 8:00 a.m. ET to discuss second quarter 2024 financial results.